{
  "ticker": "FBRX",
  "company_name": "Forte Biosciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT04504279",
      "title": "Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Atopic Dermatitis",
      "start_date": "2020-10-13",
      "completion_date": "2021-08-19",
      "enrollment": 0,
      "sponsor": "Forte Biosciences, Inc."
    },
    {
      "nct_id": "NCT04936113",
      "title": "Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study",
      "status": "TERMINATED",
      "phase": "PHASE2",
      "condition": "Atopic Dermatitis",
      "start_date": "2021-06-02",
      "completion_date": "2021-09-30",
      "enrollment": 0,
      "sponsor": "Forte Biosciences, Inc."
    },
    {
      "nct_id": "NCT06982963",
      "title": "Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Celiac Disease",
      "start_date": "2025-08-04",
      "completion_date": "2027-02-28",
      "enrollment": 0,
      "sponsor": "Forte Biosciences, Inc."
    },
    {
      "nct_id": "NCT06905873",
      "title": "A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Vitiligo",
      "start_date": "2025-03-25",
      "completion_date": "2026-12-31",
      "enrollment": 0,
      "sponsor": "Forte Biosciences, Inc."
    },
    {
      "nct_id": "NCT07205159",
      "title": "A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "Alopecia Areata",
      "start_date": "2025-10-23",
      "completion_date": "2027-03-10",
      "enrollment": 0,
      "sponsor": "Forte Biosciences, Inc."
    }
  ],
  "summary": {
    "total_trials": 5,
    "by_phase": {
      "PHASE2": 3,
      "PHASE1": 2
    },
    "by_status": {
      "COMPLETED": 1,
      "TERMINATED": 1,
      "RECRUITING": 3
    },
    "active_trials": 3,
    "completed_trials": 1,
    "conditions": [
      "Alopecia Areata",
      "Atopic Dermatitis",
      "Celiac Disease",
      "Vitiligo"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:47:24.048933",
    "search_query": "Forte Biosciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Forte+Biosciences,+Inc."
  }
}